Targeting ADAMTS1/HDAC6 alleviates TGF-β1/SMAD2-associated cardiac fibrosis in cardiac fibrosis post-myocardial infarction
Cell Biology and Toxicology · 2026
DOI: 10.1007/s10565-026-10159-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Qiao Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Third Xiangya Hospital (Central South University), Changsha, China. Hauptthemen laut MEDLINE: ADAMTS1 Protein, Smad2 Protein, Transforming Growth Factor beta1, Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Natural Science Foundation of Changsha city.
Abstract (Originalsprache)
BACKGROUND: A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1) is involved in the occurrence and development of myocardial fibrosis. Here, we sought to explore the specific regulatory mechanism of ADAMTS1 in cardiac fibrosis post-myocardial infarction (CFPMI). METHODS: Blood samples from patients with myocardial fibrosis were collected. A CFPMI mouse model and in vitro models involving human or mouse cardiac fibroblasts treated with TGF-β1 or Ang II were constructed. ChIP was used to confirm that SMAD2 binds to ADAMTS1, and Co-IP was used to verify the interaction between ADAMTS1 and HDAC6. Cellular models with SMAD2 knockdown, ADAMTS1 regulation, and HDAC6 inhibitor treatment were used to study their roles in fibrosis. Finally, AAV-shRNA-HDAC6 and ADAMTS1 inhibitor effects were verified in vivo. RESULTS: ADAMTS1 levels were higher in myocardial fibrosis patients' serum. Increased ADAMTS1 and p-SMAD2 were found in fibrotic mouse hearts and human cardiac fibroblasts stimulated with fibrotic factors. ChIP validated the binding of SMAD2 to ADAMTS1. Mechanistically, SMAD2 regulated ADAMTS1 expression during TGF-β1-induced fibrosis in human and mouse cardiac fibroblasts. Overexpression of ADAMTS1 enhanced the production of collagen fiber proteins in human and mouse cardiac fibroblasts induced by TGF-β1. Moreover, HDAC6 expression was elevated in CFPMI mouse hearts and ADAMTS1 inhibited HDAC6 to regulate fibrosis. ADAMTS1 interacted with HDAC6 during fibrosis. In vivo, shRNA-HDAC6 and ADAMTS1 inhibitor treatment alleviated myocardial fibrosis and improved cardiac function after CFPMI. CONCLUSIONS: Targeting ADAMTS1/HDAC6 alleviated TGF-β1/SMAD2-associated cardiac fibrosis in CFPMI. This study may provide a novel theoretical basis for the treatment of myocardial fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The Third Xiangya Hospital (Central South University), Changsha, China.
- Department of Cardiovascular Medicine, The Changsha Central Affiliated Hospital, Hengyang Medical School, University of South China, Changsha, China.
- Department of Medical Imaging, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China. 2018050620@usc.edu.cn.
- Department of Radiology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China. 2018050620@usc.edu.cn.
- Department of Cardiovascular Medicine, The Changsha Central Affiliated Hospital, Hengyang Medical School, University of South China, Changsha, China. 2018050779@usc.edu.cn.
Förderung
- Natural Science Foundation of Hunan Province
- Natural Science Foundation of Changsha city
Zitieren
APA
Jin, Q., Chen, C., Wu, P., Li, L., Jiang, L., Chen, R., Xu, S., Huang, Y., Xu, H., & Long, X. (2026). Targeting ADAMTS1/HDAC6 alleviates TGF-β1/SMAD2-associated cardiac fibrosis in cardiac fibrosis post-myocardial infarction. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10159-2
Vancouver
Jin Q, Chen C, Wu P, Li L, Jiang L, Chen R, et al. Targeting ADAMTS1/HDAC6 alleviates TGF-β1/SMAD2-associated cardiac fibrosis in cardiac fibrosis post-myocardial infarction. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10159-2
BibTeX
@article{Jin2026,
author = {Jin, Qiao and Chen, Chun and Wu, Pengcui and Li, Liang and Jiang, Luping and Chen, Ran and Xu, Shanxiang and Huang, Yuyan and Xu, Haixia and Long, Xiao},
title = {Targeting ADAMTS1/HDAC6 alleviates TGF-β1/SMAD2-associated cardiac fibrosis in cardiac fibrosis post-myocardial infarction},
journal = {Cell Biology and Toxicology},
year = {2026},
doi = {10.1007/s10565-026-10159-2}
}
EUVIMED